HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

AIM: To study the HER2 gene amplification or overexpression in patients with advanced gastric cancer (GC) and their association with patient characteristics and patient survival. PATIENTS AND METHODS: Tumour tissue samples from 148 patients with advanced GC were studied for HER2 by immunohistochemis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Martin, Carlos, Garralda, Elena, Echarri, M José, Ballesteros, Anabel, Arcediano, Alberto, Rodríguez-Peralto, José Luis, Hidalgo, Manuel, López-Ríos, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410298/
https://www.ncbi.nlm.nih.gov/pubmed/22569536
http://dx.doi.org/10.1136/jclinpath-2012-200774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410298/
https://www.ncbi.nlm.nih.gov/pubmed/22569536
http://dx.doi.org/10.1136/jclinpath-2012-200774

Ejemplares similares